NEOS Investment Management LLC Acquires 10,013 Shares of Danaher Corporation $DHR

NEOS Investment Management LLC boosted its holdings in Danaher Corporation (NYSE:DHR) by 10.8% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 102,582 shares of the conglomerate’s stock after acquiring an additional 10,013 shares during the quarter. NEOS Investment Management LLC’s holdings in Danaher were worth $19,540,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in DHR. JPL Wealth Management LLC purchased a new position in Danaher during the 3rd quarter worth $25,000. Main Street Group LTD purchased a new stake in shares of Danaher in the first quarter valued at about $25,000. N.E.W. Advisory Services LLC purchased a new stake in shares of Danaher in the second quarter valued at about $25,000. WFA of San Diego LLC bought a new position in shares of Danaher during the second quarter valued at about $26,000. Finally, Hilton Head Capital Partners LLC purchased a new position in Danaher during the fourth quarter worth about $27,000. 79.05% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have commented on DHR shares. Stifel Nicolaus decreased their price objective on shares of Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. Piper Sandler initiated coverage on Danaher in a research note on Thursday, June 11th. They issued a “neutral” rating and a $200.00 target price on the stock. Wolfe Research lowered Danaher from an “outperform” rating to a “peer perform” rating in a report on Monday, June 1st. DZ Bank initiated coverage on Danaher in a research report on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price target for the company. Finally, HSBC dropped their price target on Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a report on Wednesday, June 3rd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and a consensus target price of $228.91.

Danaher Trading Down 1.7%

Shares of DHR stock opened at $207.46 on Friday. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The firm has a market cap of $145.84 billion, a P/E ratio of 36.85, a PEG ratio of 2.63 and a beta of 0.78. The company has a 50 day moving average of $201.74 and a 200-day moving average of $192.28. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. During the same quarter in the prior year, the business earned $0.77 earnings per share. Danaher’s revenue for the quarter was up 5.5% on a year-over-year basis. Sell-side analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current year.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.